Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 5291-5296

  Jamal, Mohamed A ^a   Rosenblatt, Joel ^a   Jiang, Ying ^a   Hachem, Ray ^a   Chaftari, Ann Marie ^a   Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE SILVER; ANTIINFECTIVE AGENT; DISINFECTANT AGENT;

ANTIMICROBIAL CATHETER; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BIOFILM; CANDIDA ALBICANS; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CLINICAL STUDY; CROSS CONTAMINATION; CROSS INFECTION; DISEASE TRANSMISSION; ESCHERICHIA COLI; GUIDE WIRE; IN VITRO STUDY; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL CONTAMINATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; DRUG COMBINATION; DRUG EFFECTS; HUMAN; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROCEDURES; TRANSMISSION;

ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; DISINFECTANTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; MINOCYCLINE; RIFAMPIN;

EID: 84906084106     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02886-14     Document Type: Article

References (33)

1. Edgeworth JD, Treacher DF, Eykyn SJ. 1999. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit. Care Med. 27: 1421-1428. http://dx.doi.org/10.1097/00003246-199908000-00002. (Pubitemid 29406927)
2. Donlan RM. 2002. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8:881-890. http://dx.doi.org/10.3201/eid0809.020063. (Pubitemid 35000803)
3. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 1999. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887-892. http://dx.doi.org/10.1097/00003246-199905000-00020. (Pubitemid 29266004)
4. Pittet D, Tarara D, Wenzel RP. 1994. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601. http://dx.doi.org/10.1001/jama.271.20.1598.
5. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. 2002. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. MMWR Recomm. Rep. 51:1-29.
6. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45. http://dx.doi.org/10.1086/599376.
7. Pettigrew RA, Lang SD, Haydock DA, Parry BR, Bremner DA, Hill GL. 1985. Catheter-related sepsis in patients on intravenous nutrition: a prospective study of quantitative catheter cultures and guidewire changes for suspected sepsis. Br. J. Surg. 72:52-55. http://dx.doi.org/10.1002/bjs .1800720121.
8. Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA, Pruett TL, Schwenzer KJ, Farr BM. 1992. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N. Engl. J. Med. 327:1062-1068. http://dx.doi.org/10.1056/NEJM199210083271505.
9. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. 1990. Catheterrelated sepsis: prospective, randomized study of three methods of longterm catheter maintenance. Crit. Care Med. 18:1073-1079. http://dx.doi .org/10.1097/00003246- 199010000-00005. (Pubitemid 20364044)
10. Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM. 1994. Complications and failures of subclavian-vein catheterization. N. Engl. J. Med. 331:1735-1738. http://dx.doi.org/10.1056/NEJM199412293312602.
11. Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sanchez-Ortega I, Duarte R, Calvo M, Carratala J. 2011. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J. Antimicrob. Chemother. 66:657-663. http://dx.doi.org/10.1093/jac/ dkq494.
12. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011. http://dx.doi.org/10.1086/591861.
13. Lee MY, Ko KS, Song JH, Peck KR. 2007. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. J. Antimicrob. Chemother. 60:782-787. http://dx.doi.org/10.1093/jac/dkm295. (Pubitemid 47434256)
14. Michalopoulos A, Falagas ME, Karatza DC, Alexandropoulou P, Papadakis E, Gregorakos L, Chalevelakis G, Pappas G. 2011. Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant Gramnegative primary bacteremia of critically ill patients. Am. J. Infect. Control 39:396-400. http://dx.doi.org/10.1016/j.ajic.2010.06.017.
15. Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AM, Raad II. 2014. Prevention of Gram-negative bacterial biofilm on minocycline/rifampin impregnated catheters sequentially coated with chlorhexidine. Antimicrob. Agents Chemother. 58:1179-1182. http: //dx.doi.org/10.1128/AAC.01959-13.
16. Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY. 2012. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob. Agents Chemother. 56:935-941. http://dx.doi.org/10.1128 /AAC.05836-11.
17. Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, Raad I. 2006. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob. Agents Chemother. 50:3283-3288. http://dx.doi.org/10.1128/AAC.01622-05. (Pubitemid 44527499)
18. Garcia-Teresa MA, Casado-Flores J, Delgado Dominguez MA, Roqueta-Mas J, Cambra-Lasaosa F, Concha-Torre A, Fernandez-Perez C. 2007. Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study. Intensive Care Med. 33:466-476. http://dx.doi.org/10.1007/s00134-006-0508-8. (Pubitemid 46333841)
19. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. 1996. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J. Infect. Dis. 173:418-424. http://dx.doi.org/10.1093 /infdis/173.2.418. (Pubitemid 26042443)
20. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G. 1999. A comparison of two antimicrobial-impregnated central venous catheters: Catheter Study Group. N. Engl. J. Med. 340:1-8. http://dx.doi .org/10.1056/NEJM199901073400101. (Pubitemid 29024677)
21. Raad II, Darouiche RO, Hachem R, Abi-Said D, Safar H, Darnule T, Mansouri M, Morck D. 1998. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit. Care Med. 26:219-224. http://dx.doi.org/10 .1097/00003246- 199802000-00015. (Pubitemid 28082681)
22. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. 1997. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann. Intern. Med. 127:267-274. http://dx.doi.org/10.7326/0003-4819-127-4 -199708150-00002.
23. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. 2009. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 301:727-736. http://dx.doi.org/10.1001/jama.2009.153.
24. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. 2008. Anti-adherence activity and antimicrobial durability of anti-infectivecoated catheters against multidrug-resistant bacteria. J. Antimicrob. Chemother. 62:746-750. http://dx.doi.org/10.1093/jac/dkn281.
25. Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C, Brun-Buisson C. 1997. Central venous catheter replacement strategies: a systematic review of the literature. Crit. Care Med. 25:1417-1424. http: //dx.doi.org/10.1097/ 00003246-199708000-00033. (Pubitemid 27347310)
26. Parbat N, Sherry N, Bellomo R, Schneider AG, Glassford NJ, Johnson PD, Bailey M. 2013. The microbiological and clinical outcome of guide wire exchanged versus newly inserted antimicrobial surface treated central venous catheters. Crit. Care. 17:R184. http://dx.doi.org/10.1186/cc12867.
27. Chaftari AM, Kassis C, El Issa H, Al Wohoush I, Jiang Y, Rangaraj G, Caillouet B, Pravinkumar SE, Hachem RY, Raad II. 2011. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer 117: 2551-2558. http://dx.doi.org/10.1002/cncr.25807.
28. Jamal MA, Chaftari AM, Dvorak T, El Zakhem A, Rosenblatt J, Jiang Y, Hachem R, Raad II. 2013. Prevention of transmission of multidrug resistant organisms during catheter exchange using antimicrobial catheters, abstr E-622. Abstr. 53rd Intersci. Conf. Antimicrob. Agents Chemother., Denver, CO, American Society for Microbiology, Washington, DC.
29. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37:1172-1177. http: //dx.doi.org/10.1086/378745. (Pubitemid 37372504)
30. Samonis G, Vardakas KZ, Maraki S, Tansarli GS, Dimopoulou D, Kofteridis DP, Andrianaki AM, Falagas ME. 2013. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer 21:2521-2526. http://dx .doi.org/10.1007/s00520-013-1816-5.
31. Ko HK, Yu WK, Lien TC, Wang JH, Slutsky AS, Zhang H, Kou YR. 2013. Intensive care unit-acquired bacteremia in mechanically ventilated patients: clinical features and outcomes. PLoS One 8:e83298. http://dx.doi .org/10.1371/journal.pone.0083298.
32. Cairo J, Hachem R, Rangaraj G, Granwehr B, Raad I. 2011. Predictors of catheter-related Gram-negative bacilli bacteraemia among cancer patients. Clin. Microbiol. Infect. 17:1711-1716. http://dx.doi.org/10.1111/j .1469-0691.2011.03504.x.
33. Downes KJ, Metlay JP, Bell LM, McGowan KL, Elliott MR, Shah SS. 2008. Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin. Infect. Dis. 46:387-394. http://dx.doi.org/10.1086/525265. (Pubitemid 351263522)